10x Genomics, Inc. State and Local Income Tax Expense (Benefit), Continuing Operations
10x Genomics, Inc. (TXG) reported State and Local Income Tax Expense (Benefit), Continuing Operations of -$11.94 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-13
- 10x Genomics, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2024 was -$11.94M.
- 10x Genomics, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2023 was -$14.83M.
- 10x Genomics, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2022 was -$11.78M.
- 10x Genomics, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2021 was -$20.14M.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2024-12-31 | -$11.94M 10-K · filed 2026-02-13 |
| 2023-12-31 | -$14.83M 10-K · filed 2026-02-13 |
| 2022-12-31 | -$11.78M 10-K · filed 2025-02-13 |
| 2021-12-31 | -$20.14M 10-K · filed 2024-02-15 |
| 2020-12-31 | -$16.65M 10-K · filed 2023-02-16 |
| 2019-12-31 | -$2.96M 10-K · filed 2022-02-18 |
| 2018-12-31 | -$4.48M 10-K · filed 2020-02-27 |